Wamepotea (they have become lost): Outcomes of HIV-positive and HIV-exposed children lost to follow-up from a large HIV treatment program in Western Kenya

Journal of Acquired Immune Deficiency Syndromes

Volumn 57, Issue 3, 2011, Pages

  Braitstein, Paula ^a,b   Songok, Julia ^b   Vreeman, Rachel C ^a   Wools Kaloustian, Kara K ^a   Koskei, Pamela ^c   Walusuna, Leahbell ^c   Ayaya, Samwel ^b   Nyandiko, Winstone ^b   Yiannoutsos, Constantin ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOI UNIVERSITY   (Kenya)

^c USAID ^*  (United States)

Author keywords

Africa; HIV; losses to follow up; mortality; pediatrics; retention

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH AUXILIARY; HEALTH CARE COST; HEALTH CENTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; KENYA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PRESCHOOL CHILD; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOM SAMPLE; RURAL AREA; STIGMA; TRADITIONAL MEDICINE; URBAN AREA; VIROTHERAPY;

CHILD; CHILD, ORPHANED; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; INFANT; KENYA; LOST TO FOLLOW-UP; MALE; PREJUDICE; RURAL POPULATION; URBAN POPULATION;

EID: 79959749308     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182167f0d     Document Type: Article

References (28)

1. UNAIDS. AIDS Epidemic Update 2009. Geneva: UNAIDS, WHO; 2009.
2. KIDS-ART LINC Collaboration (Pediatric Antiretroviral Treatment in Lower Income Countries Collaboration). Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa. J Acquir Immune Defic Syndr. 2008;49:523-531.
3. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA. 2007;298: 1888-1899. (Pubitemid 350005233)
4. Braitstein P, Nyandiko W, Vreeman R, et al. The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment. Pediatr Infect Dis J. 2009;28:626-632.
5. Ellis J, Molyneux EM. Experience of anti-retroviral treatment for HIVinfected children in Malawi: the 1st 12 months. Ann Trop Paediatr. 2007; 27:261-267. (Pubitemid 350167611)
6. George E, Noel F, Bois G, et al. Antiretroviral therapy for HIV-1 infected children in Haiti. J Infect Dis. 2007;195:1411-1418. (Pubitemid 46717458)
7. Kiboneka A, Wangisi J, Nabiryo C, et al. Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda. AIDS. 2008;22:2493-2499.
8. Nyandiko WM, Ayaya S, Nabakwe E, et al. Outcomes of HIV-infected orphaned and non-orphaned children on antiretroviral therapy in western Kenya. J Acquir Immune Defic Syndr. 2006;43:418-425. (Pubitemid 44737098)
9. Patel K, Hernan MA, Williams PL, et al. Long-term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting. Clin Infect Dis. 2008;46:1751-1760. (Pubitemid 351706777)
10. Wamalwa DC, Farquhar C, Obimbo EM, et al. Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan children. J Acquir Immune Defic Syndr. 2007;45:311-317. (Pubitemid 47012378)
11. World Health Organization. Towards Universal Access: Scaling up Priority HIV/AIDS Interventions in the Health Sector. Geneva, Switzerland: WHO; 2009.
12. Braitstein P, Katshcke A, Shen C, et al. Retention of HIV-infected and HIV-exposed children in a comprehensive HIV clinical care programme in Western Kenya. Trop Med Int Health. 2010;15:833-841.
13. Essomo Megnier-Mbo M. Prevention of mother-to-child transmission of HIV in Gabon. The problem of children lost to follow-up [in French]. Arch Pediatr. 2008;15:1703-1704.
14. Ioannidis JP, Taha TE, Kumwenda N, et al. Predictors and impact of losses to follow-up in an HIV-1 perinatal transmission cohort in Malawi. Int J Epidemiol. 1999;28:769-775. (Pubitemid 29401340)
15. Van Kooten Niekerk NK. The first 5 years of the family clinic for HIV at Tygerberg Hospital: family demographics, survival of children and early impact of antiretroviral therapy. J Trop Pediatr. 2006;52: 3-11.
16. Einterz RM, Kimaiyo S, Mengech HN, et al. Responding to the HIV pandemic: the power of an academic medical partnership. Acad Med. 2007;82:812-818. (Pubitemid 47356397)
17. Yiannoutsos CT, An MW, Frangakis CE, et al. Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya. PLoS ONE. 2008;3:e3843.
18. Yiannoutsos CT, Ming-Wen A, Frangakis CE, et al. Patient outreach and statistical modeling in improving patient care, monitoring and evaluation in HIV treatment programs: experience of a large PEPFAR-funded program in western Kenya. PLoS Med. 2008;3: e3843.
19. Tierney WM, Rotich JK, Hannan TJ, et al. The AMPATH medical record system: creating, implementing, and sustaining an electronic medical record system to support HIV/AIDS care in western Kenya. Medinfo. 2007;12(Pt 1):372-376.
20. Brinkhof MW, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resourcelimited settings: systematic review and meta-analysis. PLoS ONE. 2009;4:e5790.
21. McGuire M, Munyenyembe T, Szumilin E, et al. Vital status of pre-ART and ART patients defaulting from care in rural Malawi. Trop Med Int Health. 2010;15(Suppl 1):55-62.
22. Vreeman RC, Nyandiko WM, Ayaya SO, et al. Factors sustaining pediatric adherence to antiretroviral therapy in western Kenya. Qual Health Res. 2009;19:1716-1729.
23. Vreeman RC, Nyandiko WM, Ayaya SO, et al. The perceived impact of disclosure of pediatric HIV status on pediatric antiretroviral therapy adherence, child well-being, and social relationships in a resource-limited setting. AIDS Patient Care STDS. 2010;24(10):639-649.
24. Anglaret X, Toure S, Gourvellec G, et al. Impact of vital status investigation procedures on estimates of survival in cohorts of HIVinfected patients from Sub-Saharan Africa. J Acquir Immune Defic Syndr. 2004;35:320-323. (Pubitemid 38280660)
25. Geng EH, Emenyonu N, Bwana MB, et al. Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. JAMA. 2008;300: 506-507.
26. Vreeman RC, Wiehe SE, Pearce EC, et al. A systematic review of pediatric adherence to antiretroviral therapy in low- and middle-income countries. Pediatr Infect Dis J. 2008;27:686-691.
27. Ochieng VO, Ochieng D, Sidle JE, et al.Gender and Losses to Follow up From a Large HIV Treatment Program in Western Kenya. Bulletin of the World Health Organization. epub 16 April, 2010.
28. Raguenaud ME, Isaakidis P, Zachariah R, et al. Excellent outcomes among HIV+ children on ART, but unacceptably high pre-ART mortality and losses to follow-up: a cohort study from Cambodia. BMC Pediatr. 2009;9:54.